NCT03717142: Feasibility of the LUM Imaging System for Detection of Cancer to the Brain

NCT03717142
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must be scheduled for surgical resection
Exclusions: Patients previously treated with systemic therapies to treat the cancer to be removed
https://ClinicalTrials.gov/show/NCT03717142

Comments are closed.

Up ↑